Back to search
FDAFDA · Food and drugs·Recall number D-0036-2015

Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07

Published October 29, 2014 · Recall initiated: September 26, 2014

Summary

FDA records drug Class II recall D-0036-2015, published October 29, 2014 and initiated September 26, 2014. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 94,584 cartons; Lot: Lot A369286, exp. date 31 Jan 2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; at the 6-month stability time point

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Forest Pharmaceuticals Inc
Distributor
Nationwide including Puerto Rico.
Lot
Lot A369286, exp. date 31 Jan 2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07 recalled?

Yes. FDA published recall D-0036-2015 on October 29, 2014. Reported hazard: Failed Dissolution Specification; at the 6-month stability time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter